by CheckRare Staff | Nov 15, 2022
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome. As Dr. Ticho explains, Dravet syndrome is a rare neurological condition that usually...
by CheckRare Staff | Nov 8, 2022
Gustavo A. Heresi, MD, MS, Director of the Pulmonary Vascular and Chronic Thromboembolic Pulmonary Hypertension Program in the Department of Pulmonary and Critical Care Medicine in the Respiratory Institute at Cleveland Clinic discusses caring for patients with...
by CheckRare Staff | Nov 4, 2022
Alex Kolevzon, MD, Professor of Psychiatry and Pediatrics at the Icahn School of Medicine at Mount Sinai, explains the pathophysiology of Phelan-McDermid syndrome and how it is current treated. Phelan-McDermid syndrome is genetic disorder and one of few known...
by CheckRare Staff | Oct 12, 2022
« Prev1 / 1Next »Galactosemia Roundtable DiscussionGalactosemia Foundation OverviewGalactosemia Expert PerspectivesPatient AdvocacyGalactosemia Family Story: Allison and BrooksGalactosemia Family Story: Megan and AvaGalactosemia Family Story: David and...
by CheckRare Staff | Sep 20, 2022
Ronald Oudiz, MD, FACP, FACC, FCCP, Professor of Medicine, Director, Pulmonary Hypertension Clinic, Chief, Division of Cardiology, Harbor-UCLA Medical Center, discusses pulmonary arterial hypertension (PAH) and ways to engage with care teams for increased...
